CONTERNO, NCT04786964: Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab (CK-301) in First Line Metastatic Non-squamous Non-Small Cell Lung Cancer |
|
|
| Terminated | 3 | 25 | RoW | Cosibelimab, Cisplatin, Carboplatin, Pemetrexed, Folic acid 350-1000 μg, Vitamin B12 1000 μg, Dexamethasone 4mg | Checkpoint Therapeutics, Inc. | Metastatic Non-squamous Non Small Cell Lung Cancer | 12/22 | 12/22 | | |
